ARTL Earnings

Quarterly EPS
$-56.70
Q3 2024
$-71.01
Q4 2024
$-112.95
Q1 2025
$-151.74
Q2 2025
$-107.19
Q3 2025
$-38.14
Q4 2025
$-36.00
Q1 2026
$-8.01
Q2 2026
Latest RevenueN/A
Latest Net Income-2427000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$8.010-2427000+94.7%
Q1 2026-$36.000-2958000+68.1%
Q4 2025-$38.140-4166000+46.3%
Q3 2025-$107.190-3120000-89.0%
Q2 2025-$151.740-3221000-24.3%
Q1 2025-$112.950-2372000+10.6%
Q4 2024-$71.010-3778000+54.7%
Q3 2024-$56.700-1132000+57.8%
Q2 2024-$122.040-2433000
Q1 2024-$126.360-2483000
Q4 2023-$156.600-3073000
Q3 2023-$134.460-2449000
Artelo Biosciences (ARTL) — Earnings